Digg It - Business

If you stay in business long enough you will witness the good side and the bad side of business life. It i

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

s an unfortunate fact of life that things never run smoothly all of the time, in fact they have a way of t

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

urning bad when least expected.

One of the most difficult decisions a business owner can face, is decidin

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

g if their businesses worth recovering? To find the true answer to this question it is sometimes worth emp

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

loying the opinion of an outside agency. This agency will carry out a complete audit and report their find

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

ing to you, the good thing about employing an outside agency is they are devoid of emotion towards the bus

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

iness and deal purely with facts and figures.

If the company is deemed recoverable a recovery package can

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

be put in place, generally this comes in the form of a long term loan. Most recovery loans come with stip

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ulations; the reason is to prevent the business failing in the future. Businesses the world over will come

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

across difficult times, for various reasons, the one factor that separates successful businessmen from th

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

eir peers is lessons are learned by their mistakes and errors of judgement.

Administrators are usually ca

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

lled in for large or PLC’s (Public Limited Company) that find themselves in financial trouble. This normal

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

ly happens after financial support for the company is withdrawn. News that the Administrators have been ca

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

lled in usually result in the mass ‘sell off’ of company shares; this compounds the problems even more. Th

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

e Administrators will carry out a complete audit and ascertain if there is anything left of value after al

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

l debts are paid. Generally speaking debts are not payable and the company is listed as bankrupt. However

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

on the odd occasion the Administrators will see value in keeping the company afloat, a recovery package is

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

put in place and things have been known to eventually turn around totally.

If you would like any more in

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

formation on this subject then please visit our website at elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

om">www.bizseller4u.com, we have a team of experts who are well versed in the art of business recovery

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/2384/diggit-Business-Recovery.html">Business Recovery</a>

BB link (for phorums):
[url=http://www.diggit.org.ua/article/2384/diggit-Business-Recovery.html]Business Recovery[/url]

Storm clouds are hovering in the drug research domain where Indian companies have raked in the moolah from a string of successful discoveries. Research costs are on the rise and the chances of success in discoveries are less. The time to develop new drugs has also lengthened. A few years ago, it took around two years to launch a new drug; it now takes over six after approvals and clinical trials.

One thing that all business owners, managers, and shareholders have in common is that we all want to make money! The methodology and the understanding of how to make money varies widely, yest less than 20% of businesses really make an acceptable profit, which is bankable - Why?

Tags

Links

Digg It - Business Recovery

Related Articles: